ZMIZ1 and myeloid sarcoma: However, a study with 39 Caucasian subjects from a cross-section of patients with MS receiving treatment with DMF in Australia and the United States and 40 healthy subjects showed greater expression of the ZMIZ1 gene in patients treated with DMF compared to those not treated with this drug (p = 0.031, CV = 32%) [31].